BRUSSELS (Reuters) – Johnson & Johnson (JNJ.N) could produce 1 billion doses of its potential COVID-19 vaccine next year if it proves successful and would consider injecting healthy volunteers with the new coronavirus if there are not enough patients for definitive studies, a company member said. FILE PHOTO: Small bottles …
Read More »
FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against coronavirus (COVID-19), in Cambridge, Massachusetts, US, May 18, 2020. REUTERS / Brian Snyder (Reuters) – Modern Inc (MRNA.O) said there was a possibility that it was not the first company to make breakthroughs required …
Read More »
(Reuters) – Politicians, drugmakers and regulators around the world offer conflicting views on whether a COVID-19 vaccine will be ready. Much depends on what ‘ready’ means and for what group of people. Some important questions about the timeline are: FILE PHOTO: A woman holding a small bottle labeled “Vaccine COVID-19” …
Read More »
(Reuters) – The number of new COVID-19 cases among children in the United States has increased 40% in the last two weeks of July, according to a report released just weeks before tens of millions of American students are scheduled to start the new school year. PHILO PHOTO: A child …
Read More »
FILE PHOTO: Chinese fax manufacturer CanSino Biologics’ sign is pictured at its building in Tianjin, China November 20, 2018. REUTERS / Stringer / File Photo DUBAI (Reuters) – Saudi Arabia will soon begin Phase III clinical trials on about 5,000 people for a COVID-19 vaccine developed by China’s CanSino Biologics …
Read More »